{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T12:56:46Z","timestamp":1794661006598,"version":"4.9.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-12371-7","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T10:37:35Z","timestamp":1766399855000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Epidemiology and risk factors of multidrug-resistant Gram-negative bacilli in healthcare-associated infections: development of an exploratory risk assessment model in a Moroccan regional hospital"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2255-5213","authenticated-orcid":false,"given":"Asmaa","family":"Dihmane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4360-9580","authenticated-orcid":false,"given":"Rafik","family":"Aniba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habiba","family":"Raqraq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Ressmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaotar","family":"Nayme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Timinouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abouddihaj","family":"Barguigua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"issue":"10","key":"12371_CR1","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3390\/pathogens10101310","volume":"10","author":"G Mancuso","year":"2021","unstructured":"Mancuso G, Midiri A, Gerace E, Biondo C. Bacterial antibiotic resistance: the most critical pathogens. Pathogens. 2021;10(10):1310.","journal-title":"Pathogens"},{"key":"12371_CR2","doi-asserted-by":"crossref","unstructured":"Talaat M, Zayed B, Tolba S, Abdou E, Gomaa M, Itani D, et al. Increasing antimicrobial resistance in World Health Organization Eastern Mediterranean Region, 2017-2019. Emerging Infect Dis J. 2022;28(4).","DOI":"10.3201\/eid2804.211975"},{"key":"12371_CR3","first-page":"1","volume-title":"Advances in botanical research","author":"H Fongang","year":"2023","unstructured":"Fongang H, Mbaveng AT, Kuete V. Global burden of bacterial infections and drug resistance. In: Advances in botanical research. Academic Press; 2023. p. 1\u201320."},{"issue":"3","key":"12371_CR4","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. The Lancet Infect Dis. 2018;18(3):318\u201327.","journal-title":"The Lancet Infect Dis"},{"issue":"215","key":"12371_CR5","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1093\/infdis\/jiw282","volume":"15","author":"LK Logan","year":"2017","unstructured":"Logan LK, Weinstein RA. The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace. J Infect Dis. 2017, Feb;15(215(suppl 1): S28\u201336.","journal-title":"J Infect Dis"},{"key":"12371_CR6","unstructured":"World Health Organization. WHO publishes list of bacteria for which new antibiotics are urgently needed. 2017.Available from https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed. cited 2025 Oct 6]."},{"issue":"1","key":"12371_CR7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12911-024-02504-4","volume":"24","author":"Q Liang","year":"2024","unstructured":"Liang Q, Ding S, Chen J, Chen X, Xu Y, Xu Z, et al. Prediction of carbapenem-resistant Gram-negative bacterial bloodstream infection in intensive care unit based on machine learning. BMC Med Inf Decis Mak. 2024;24(1):123.","journal-title":"BMC Med Inf And Decis Mak"},{"key":"12371_CR8","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1186\/s12879-014-0615-z","volume":"14","author":"A Vasudevan","year":"2014","unstructured":"Vasudevan A, Mukhopadhyay A, Li J, Yuen EGY, Tambyah PA. A prediction tool for nosocomial multi-drug resistant Gram-negative bacilli infections in critically ill patients - prospective observational study. BMC Infect Dis. 2014, Nov, 25;14:615.","journal-title":"BMC Infect Dis"},{"issue":"11","key":"12371_CR9","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3390\/tropicalmed7110328","volume":"7","author":"J Ponyon","year":"2022","unstructured":"Ponyon J, Kerdsin A, Preeprem T, Ungcharoen R. Risk factors of infections due to multidrug-resistant Gram-negative bacteria in a community hospital in Rural Thailand. Trop Med Infect Dis. 2022, Oct, 23;7(11):328.","journal-title":"Trop Med Infect Dis"},{"issue":"53","key":"12371_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ejim.2018.01.029","volume":"1","author":"M Falcone","year":"2018","unstructured":"Falcone M, Tiseo G, Dentali F, Regina ML, Foglia E, Gambacorta M, et al. Predicting resistant etiology in hospitalized patients with blood cultures positive for Gram-negative bacilli. Eur J Intern Med. 2018, Jul;1(53):21\u201328.","journal-title":"Eur J Intern Med"},{"issue":"1","key":"12371_CR11","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1186\/s12879-019-4363-y","volume":"19","author":"TP Lodise","year":"2019","unstructured":"Lodise TP, Bonine NG, Ye JM, Folse HJ, Gillard P. Development of a bedside tool to predict the probability of drug-resistant pathogens among hospitalized adult patients with gram-negative infections. BMC Infect Dis. 2019, Aug, 14;19(1):718.","journal-title":"BMC Infect Dis"},{"issue":"15","key":"12371_CR12","doi-asserted-by":"publisher","first-page":"5691","DOI":"10.2147\/IDR.S373065","volume":"1","author":"S Nachate","year":"2022","unstructured":"Nachate S, Rouhi S, Ouassif H, Bennani H, Hachimi A, Mouaffak Y, et al. Multidrug-resistant bacteria isolated from blood culture samples in a Moroccan tertiary hospital: true bacteremia or contamination? Infect Drug Resist. 2022, Jan;1(15):5691\u2013704.","journal-title":"Infect And Drug Resist"},{"issue":"4","key":"12371_CR13","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.jiph.2019.08.012","volume":"13","author":"E A","year":"2020","unstructured":"El mekes A, Zahlane K, Ait L, Tadlaoui Ouafi A, Barakate M. The clinical and epidemiological risk factors of infections due to multi-drug resistant bacteria in an adult intensive care unit of University hospital center in Marrakesh-Morocco. J Infect And Public Health. 2020, Apr, 1;13(4):637\u201343.","journal-title":"J Infect And Public Health"},{"issue":"3","key":"12371_CR14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.afju.2015.02.005","volume":"21","author":"E MC","year":"2015","unstructured":"El bouamri MC, Arsalane L, Zerouali K, Katfy K, El Kamouni Y, Zouhair S. Molecular characterization of extended spectrum \u03b2-lactamase-producing Escherichia coli in a university hospital in Morocco, North Africa. Afr J Urology. 2015, Sep, 1;21(3):161\u201366.","journal-title":"Afr J Urology"},{"key":"12371_CR15","unstructured":"Centers for Disease Control and Prevention (CDC). Identifying healthcare-associated infections (HAI) for NHSN surveillance. Atlanta (GA): CDC; 2023 [cited 2025 Dec 16]. Available from: https:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/2psc_identifyinghais_nhsncurrent.pdf."},{"key":"12371_CR16","volume-title":"Point prevalence survey of healthcareassociated infections and antimicrobial use in European acute care hospitals","author":"European Centre for Disease Prevention and Control","year":"2024","unstructured":"European Centre for Disease Prevention and Control. Point prevalence survey of healthcareassociated infections and antimicrobial use in European acute care hospitals. Stockholm: ECDC; 2024."},{"issue":"3","key":"12371_CR17","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012, Mar, 1;18(3):268\u201381.","journal-title":"Clin Microbiol And Infect"},{"key":"12371_CR18","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/B978-0-7020-4089-4.00090-1","volume-title":"Medical microbiology","author":"RCB Slack","year":"2012","unstructured":"Slack RCB. Hospital infection. In: Greenwood D, Barer M, Slack R, Irving W, editors. Medical microbiology. (Eighteenth Ed.). Edinburgh: Churchill Livingstone; 2012. p. 718\u201326.","edition":"Eighteenth"},{"key":"12371_CR19","doi-asserted-by":"crossref","unstructured":"Deng B, Li P, Liu Y, Xie J, Huang Y, Sun Q, et al. Investigation of hospital-acquired infections prevalence and analysis of influencing factors: a case study of a specialized infectious disease hospital in Chongqing, 2017-2023. Front Public Health. 2024;12.","DOI":"10.3389\/fpubh.2024.1417645"},{"key":"12371_CR20","first-page":"44","volume-title":"European Committee on Antimicrobial Susceptibility Testing. Recommandations 2022 V.1.0 Mai. Comit\u00e9 de l\u2019Antibiogramme de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie (CA-SFM\/EUCAST)","author":"SF de Microbiologie","year":"2022","unstructured":"Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie. European Committee on Antimicrobial Susceptibility Testing. Recommandations 2022 V.1.0 Mai. Comit\u00e9 de l\u2019Antibiogramme de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie (CA-SFM\/EUCAST). Paris: SFM; 2022. p. 44\u2013128 ."},{"issue":"1","key":"12371_CR21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1128\/aem.46.1.165-170.1983","volume":"46","author":"PH Krumperman","year":"1983","unstructured":"Krumperman PH. Multiple antibiotic resistance indexing of Escherichia coli to identify high-risk sources of fecal contamination of foods. Appl Environ Microbiol. 1983, Jul;46(1):165\u201370.","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"12371_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.7326\/M14-0697","volume":"162","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons KGM. Transparent reporting of a multivariable prediction model for Individual Prognosis or diagnosis (TRIPOD): the TRIPOD statement. Ann Intern Med. 2015, Jan, 6;162(1):55\u201363.","journal-title":"Ann Intern Med"},{"issue":"1","key":"12371_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.7326\/M18-1376","volume":"170","author":"RF Wolff","year":"2019","unstructured":"Wolff RF, Moons KGM, Riley RD, Whiting PF, Westwood M, Collins GS, et al. PROBAST: a tool to assess the risk of bias and applicability of prediction model studies. Ann Intern Med. 2019, Jan;170(1):51\u201358.","journal-title":"Ann Intern Med"},{"issue":"29","key":"12371_CR24","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1093\/eurheartj\/ehu207","volume":"35","author":"EW Steyerberg","year":"2014","unstructured":"Steyerberg EW, Vergouwe Y. Towards better clinical prediction models: seven steps for development and an ABCD for validation. Eur Heart J. 2014, Aug, 1;35(29):1925\u201331.","journal-title":"Eur Heart J"},{"issue":"10325","key":"12371_CR25","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJL Murray","year":"2022","unstructured":"Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Aguilar GR, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet. 2022, Feb, 12;399(10325):629\u201355.","journal-title":"The Lancet"},{"key":"12371_CR26","unstructured":"World Health Organization. Global antimicrobial resistance and use surveillance system (GLASS) report. 2022. Geneva: World Health Organization."},{"issue":"9","key":"12371_CR27","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.3390\/antibiotics12091425","volume":"12","author":"L Badger-Emeka","year":"2023","unstructured":"Badger-Emeka L, Al Rashed AS, Aljindan RY, Emeka PM, Quadri SA, Almutairi HH. Incidence of drug-resistant hospital-associated Gram-negative bacterial infections, the accompanying risk factors, and clinical outcomes with treatment. Antibiot (Basel). 2023, Sep, 9;12(9):1425.","journal-title":"Antibiot (Basel)"},{"key":"12371_CR28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.11604\/pamj.2023.45.41.34457","volume":"45","author":"I Zalegh","year":"2023","unstructured":"Zalegh I, Chaoui L, Maaloum F, Zerouali K, Mhand RA. Prevalence of multidrug-resistant and extensively drug-resistant phenotypes of Gram-negative bacilli isolated in clinical specimens at Centre Hospitalo-Universitaire Ibn Rochd, Morocco. Pan Afr Med J. 2023, May, 17;45:41.","journal-title":"Pan Afr Med J"},{"issue":"1","key":"12371_CR29","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1186\/1471-2334-12-375","volume":"12","author":"T Cardoso","year":"2012","unstructured":"Cardoso T, Ribeiro O, Arag\u00e3o IC, Costa-Pereira A, Sarmento AE. Additional risk factors for infection by multidrug-resistant pathogens in healthcare-associated infection: a large cohort study. BMC Infect Dis. 2012, Dec;12(1):375.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"12371_CR30","doi-asserted-by":"publisher","first-page":"5262","DOI":"10.1128\/AAC.02582-14","volume":"58","author":"AE Gross","year":"2014","unstructured":"Gross AE, Van Schooneveld TC, Olsen KM, Rupp ME, Bui TH, Forsung E, et al. Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia. Antimicrob Agents Chemother. 2014, Sep;58(9):5262\u201368.","journal-title":"Antimicrob Agents Chemother"},{"key":"12371_CR31","doi-asserted-by":"publisher","first-page":"993","DOI":"10.2147\/IDR.S204671","volume":"12","author":"DY Feng","year":"2019","unstructured":"Feng DY, Zhou YQ, Zou XL, Zhou M, Zhu JX, Wang YH, et al. Differences in microbial etiology between hospital-acquired pneumonia and ventilator-associated pneumonia: a single-center retrospective study in guang Zhou. Infect Drug Resist. 2019;12:993\u20131000.","journal-title":"Infect Drug Resist"},{"issue":"3","key":"12371_CR32","doi-asserted-by":"publisher","first-page":"e34254","DOI":"10.1371\/journal.pone.0034254","volume":"7","author":"J Teo","year":"2012","unstructured":"Teo J, Cai Y, Tang S, Lee W, Tan TY, Tan TT, et al. Risk factors, molecular epidemiology and outcomes of ertapenem-resistant, carbapenem-susceptible Enterobacteriaceae: a case-case-control study. PLoS One. 2012;7(3):e34254.","journal-title":"PLoS One"},{"issue":"5","key":"12371_CR33","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/resp.13663","volume":"25","author":"D Villafuerte","year":"2020","unstructured":"Villafuerte D, Aliberti S, Soni NJ, Faverio P, Marcos PJ, Wunderink RG, et al. Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia. Respirology. 2020, May;25(5):543\u201351.","journal-title":"Respirology"},{"key":"12371_CR34","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.2147\/IDR.S317233","volume":"14","author":"H Zhang","year":"2021","unstructured":"Zhang H, Wang J, Zhou W, Yang M, Wang R, Yan X, et al. Risk factors and Prognosis of carbapenem-resistant Klebsiella pneumoniae infections in respiratory intensive care unit: a retrospective study. Infect Drug Resist. 2021, Aug, 19;14:3297\u2013305.","journal-title":"Infect Drug Resist"},{"issue":"10","key":"12371_CR35","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.ajic.2021.04.077","volume":"49","author":"VD Rosenthal","year":"2021","unstructured":"Rosenthal VD, Duszynska W, Ider BE, Gurskis V, Al-Ruzzieh MA, Myatra SN, et al. International nosocomial infection control Consortium (INICC) report, data summary of 45 countries for 2013-2018, adult and pediatric units, device-associated module. Am J Infect Control. 2021, Oct, 1;49(10):1267\u201374.","journal-title":"Am J Infect Control"},{"key":"12371_CR36","doi-asserted-by":"crossref","unstructured":"Nguyen TNT, Nguyen PLN, Le NTQ, Nguyen LPH, Duong TB, Ho NDT, et al. Emerging carbapenem-resistant Klebsiella pneumoniae sequence type 16 causing multiple outbreaks in a tertiary hospital in southern Vietnam. Microbial genomics. 2021 Feb 10;mgen000519.","DOI":"10.1099\/mgen.0.000519"},{"key":"12371_CR37","doi-asserted-by":"crossref","unstructured":"Benaissa E, Abassour T, Belouad E, Maleb A, Elouennass M. Characterization of imipenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa clinical isolates in a Moroccan hospital. 2022, May, 11.","DOI":"10.1556\/030.2022.01748"},{"issue":"3","key":"12371_CR38","doi-asserted-by":"publisher","first-page":"133","DOI":"10.18683\/germs.2019.1168","volume":"9","author":"H El Hafa","year":"2019","unstructured":"El Hafa H, Nayme K, El Hamzaoui N, Maroui I, Sbiti M, Zerouali K, et al. Dissemination of carbapenem-resistant Acinetobacter baumannii strains carrying the blaGES, blaNDM and blaOXA23 in Morocco. GERMS. 2019, Jan;9(3):133\u201341.","journal-title":"GERMS"},{"issue":"3","key":"12371_CR39","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3390\/ijerph19031039","volume":"19","author":"NF Fern\u00e1ndez-Mart\u00ednez","year":"2022","unstructured":"Fern\u00e1ndez-Mart\u00ednez NF, C\u00e1rcel-Fern\u00e1ndez S, De la Fuente-Martos C, Ruiz-Montero R, Guzm\u00e1n-Herrador BR, Le\u00f3n-L\u00f3pez R, et al. Risk factors for multidrug-resistant Gram-negative bacteria carriage upon admission to the intensive care unit. Int J Environ Res Public Health. 2022, Jan;19(3):1039.","journal-title":"Int J Environ Res And Public Health"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12371-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12371-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12371-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T20:34:04Z","timestamp":1767040444000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12371-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12371"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12371-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"15 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Comit\u00e9 d\u2019\u00c9thique pour la Recherche Biom\u00e9dicale d\u2019Oujda, affiliated with the Faculty of Medicine and Pharmacy, Mohammed First University, Oujda, Morocco (Approval No. 22\/2021). and the National Commission for the Protection of Personal Data (authorization No A-RS-255\/2021). All procedures involving human participants were conducted in accordance with the ethical standards of these institutions, national regulations, and the 1964 Helsinki Declaration and its amendments or equivalent ethical standards. Written informed consent was obtained from all participants prior to sample collection and data analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1790"}}